Staphylococcal enterotoxin-A directly stimulates signal transduction and interferon-γ production in psoriatic T-cell lines

Tissue Antigens

Volumn 52, Issue 6, 1998, Pages 530-538

  Nielsen, Mai Brit ^a,c   Odum N ^a   Gerwien, J ^a   Svejgaard, A ^a   Bendtzen, K ^a   Bregentholt, S ^a   Ropke C ^a   Geisler, C ^a   Dohlsten, M ^b   Kaltoft, K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Pharmacia and Upjohn   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

IFN ; Psoriasis; SEA; Signal transduction; T cells

Indexed keywords

GAMMA INTERFERON; STAPHYLOCOCCUS ENTEROTOXIN A; TYROSINE;

ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; CASE REPORT; CELL LINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PSORIASIS VULGARIS; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS;

EID: 0032408171     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03083.x     Document Type: Article

References (26)

1. Webb SR, Gascoigne NR. T-cell activation by superantigens. Curr Opin Immunol 1994: 6: 467-75.
2. Strange P, Cooper KD, Hansen ER et al. T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol 1993: 101: 695-700.
3. Gottlieb S, Gilleaudeau P, Johnson R et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995: 1: 442-7.
4. Leung D, Gately M, Trumble A, Fergusson-Darnell B, Schlievert P, Picker L. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 1995: 181: 747-53.
5. Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995: 16: 145-9.
6. Goodman MM, White GM, McCormick A, McCullogh J, Weinstein G. Cyclosporine therapy for psoriasis: a cell cycle-derived dosing schedule. J Am Acad Dermatol 1992: 27: 594-8.
7. Christophers E. The immunopathology of psoriasis. Int Arch Allergy Immunol 1996: 110: 199-206.
8. Michel G, Kemeny L, Homey B, Ruzicka T. FK506 in the treatment of inflammatory skin disease: promises and perspectives. Immunol Today 1996: 17: 106-8.
9. Lewis HM, Baker BS, Bokth S, Powles AV, Garioch JJ, Valdimarsson HF. Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 1993: 129: 514-20.
10. Leung DY, Travers JB, Giorno R et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995: 96: 2106-12.
11. Bour H, Demidem A, Garrigue JL, Krasteva M, Schmitt D, Claudy AN. In vitro T cell response to staphylococcal enterotoxin B superantigen in chronic plaque type psoriasis. Acta Derm Venereol 1995: 75: 218-21.
12. Boehncke WH. Psoriasis and bacterial superantigens - formal or causal correlation? Trends Microbiol 1996: 4: 485-9.
13. Karp DR, Jenkins RN, Long EO. Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins. Proc Natl Acad Sci U S A 1992: 89: 9657-61.
14. Dellabona P, Peccoud J, Kappler J, Marrack P, Benoist C, Mathis D. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 1990: 62: 1115-21.
15. Choi YW, Herman A, DiGiusto D, Wade T, Marrack P, Kappler J. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature 1990: 346: 471-3.
16. Newton DW, Dohlsten M, Olsson C et al. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity. J Immunol 1996: 157: 3988-94.
17. Kaltoft K, Hansen B, Pedersen C, Pedersen S, Thestrup-Pedersen K. Common clonal chromosome aberrations in cytokine-dependent continuous human T-lymphocyte cell lines. Cancer Genet Cytogenet. 1995: 85: 68-71.
18. Antonsson P, Wingren AG, Hansson J, Kalland T, Varga M, Dohlsten M. Functional characterization of the interaction between the superantigen staphylococcal enterotoxin A and the TCR. J Immunol 1997: 158: 4245-51.
19. Abrahamsen L, Hohlsten M, Segren S, Björk P, Jonsson E, Kalland T. Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J 1995: 14: 2978-86.
20. Nielsen M, Ødum N, Bendtzen K, Ryder LP, Jakobsen BK, Svejgaard A. MHC class II molecules regulate growth in human T cells. Exp Clin Immunogenet 1994: 11: 23-32.
21. Gerwien J, Kaltoft K, Nielsen M et al. Staphylococcus enterotoxin A modulates interleukin 15-induced signaling and mitogenesis in human T cells. Tissue Antigens 1998: 51: 164-73.
22. Lanzavecchia A. Understanding the mechanisms of sustained signaling and T cell activation. J Exp Med 1997: 185: 1717-9.
23. FitzGerald O, Kane D. Clinical, immunopathogenic, and therapeutic aspects of psoriasis arthritis. Curr Opin Rheumatol 1997: 9: 295-301.
24. Prinz J. Psoriasis vulgaris, streptococci and the immune system: a riddle to be solved soon? Scand J Immunol 1997: 48: 583-6.
25. Kanner SB, Ødum N, Grosmaire L, Masewicz S, Svejgaard A, Ledbetter JA. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells. J Immunol 1992: 149: 3482-8.
26. Wade WF, Davoust J, Salamero J, Andre P, Watts TH, Cambier JC. Structural compartmentalization of MHC class II signaling function. Immunol Today 1993: 14: 539-46.